Should the intellectual property rights on the first Covid-19 vaccines be temporarily lifted in applying the Trade …-Related Aspect of Intellectual Property (TRIPS) flexibility? Is it right to grant the first generation of Covid-19 vaccines a special … in granting broad worldwide access to vaccination. The accumulated delays in providing effective Covid-19 vaccine …

beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production … and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the … access to vaccines not until 2024. While advanced purchase agreements (APAs) among pharmaceutical companies and some …

This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or … applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines …

development will be financially sustainable for the private sector and that effective vaccines will be available to prevent the …

and the scientific, technological and industrial development of vaccines and find that certain elements of the industry … policies to boost supply and drive demand, paying particular attention to the inequity in the global distribution of vaccines …

COVID-19 vaccines. These vaccines have accounted for 99% of the global COVID-19 vaccine production as of 31 December 2021 … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed … trends of innovation and patenting activities of COVID-19 vaccines in WTO Members, and presents the legal status of the 74 …